Votes and Verdicts: Bayer, Abbott, J&J Billion-Dollar Tort Risk
Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode,...
By Aditya Somani · Bloomberg
Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode, BI litigation analysts Holly Froum and Matthew Schettenhelm are joined by mass tort expert Joseph Fantini to discuss some of the major hurdles facing companies, including weedkiller cancer claims against Bayer’s Monsanto, NEC litigation against Abbott and Reckitt’s Mead Johnson unit, talc liti